ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

CDXC ChromaDex Corporation

3.80
0.00 (0.00%)
最終更新日: 00:45:47
15分遅延
名称 銘柄コード 市場 種別
ChromaDex Corporation CDXC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 3.80 00:45:47
始値 安値 高値 終値 前日終値
3.85 3.79 3.89 3.80
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3021:32BWChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR),..
2024/4/2521:34BWChromaDex Announces Nationwide Launch of Tru Niagen® at The..
2024/4/2421:34BWChromaDex to Report First Quarter 2024 Financial Results on..
2024/4/2321:32BWChromaDex Announces Inaugural Major Grocery Debut of Tru..
2024/3/2621:32BWChromaDex Announces Tru Niagen® is Now Third-Party Verified..
2024/3/0706:04BWChromaDex Corporation Reports Fourth Quarter and Fiscal Year..
2024/3/0706:02EDGAR2Form 8-K - Current report
2024/3/0706:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2410:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2122:32BWChromaDex to Report Fourth Quarter 2023 Financial Results on..
2024/2/0522:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
2024/1/2706:08BWChromaDex to Present at the Lytham Partners 2024 Investor..
2023/12/2023:04BWChromaDex Supports the US Military with its Industry Leading..
2023/12/1406:00EDGAR2Form 8-K - Current report
2023/12/1300:30PRNUSNeurohacker Collective and ChromaDex Partner to Optimize..
2023/12/0506:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/3022:34BWA Milestone Phase I Randomized, Double-Blind Clinical Trial..
2023/11/1522:32BWNewly Published Phase II Clinical Study Demonstrates that..
2023/11/0922:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
2023/11/0906:02EDGAR2Form 8-K - Current report
2023/11/0906:02BWChromaDex Corporation Reports Third Quarter 2023 Financial..
2023/11/0906:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0121:34BWChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg..
2023/10/3121:34BWChromaDex to Report Third Quarter 2023 Financial Results on..
2023/10/2621:32BWChromaDex and Zesty Paws® Crack the Code on Cellular Health..
2023/10/0221:32BWA Milestone Clinical Study Reveals that Elevating..
2023/9/0719:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0719:20EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/8/2421:32BWPreclinical Study Builds on Growing Body of Evidence..
2023/8/1610:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1005:02EDGAR2Form 8-K - Current report
2023/8/1005:02BWChromaDex Corporation Reports Second Quarter 2023 Financial..
2023/8/1005:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0821:34BWChromaDex Launches Tru Niagen® with iHerb, the World’s..
2023/8/0721:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
2023/8/0221:02BWChromaDex to Report Second Quarter 2023 Financial Results on..
2023/7/1821:32BWFindings from Published Abstracts Showcase the Importance of..
2023/7/0705:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/0613:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/6/1621:32BWChromaDex, a Global Authority on Nicotinamide Adenine..
2023/5/3021:34BWChromaDex to Participate in the LD Micro Invitational XIII
2023/5/1121:34BWChromaDex to Present at the Lytham Partners Spring 2023..
2023/5/1105:02BWChromaDex Corporation Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock